Form 4: Applied Therapeutics Director Stacy J. Kanter Reports Acquisition of 45,000 Shares

Director Stacy J. Kanter acquired 45,000 shares of Applied Therapeutics, Inc. common stock on June 6, 2024, through compensatory Restricted Stock Units.

Summary

• On June 6, 2024, Stacy J. Kanter, a director of Applied Therapeutics, Inc., acquired 45,000 shares of common stock.
• The acquisition was made through compensatory Restricted Stock Units (RSUs) granted under the company's 2019 Equity Incentive Plan.
• Each RSU represents a contingent right to receive one share of Applied Therapeutics common stock.
• The RSUs vest quarterly from June 6, 2024, until the earlier of the first anniversary of the grant date or the date of the issuer's next annual stockholder meeting, subject to continuous service.
• Following the transaction, Kanter directly owns 108,000 shares of Applied Therapeutics common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally a positive sign, indicating confidence in the company. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of shares by a director signals confidence in the company's future prospects.
• The use of RSUs as compensation aligns the director's interests with those of the shareholders.

Future Outlook

The vesting schedule of the RSUs is contingent upon the reporting person's continuous service, incentivizing continued involvement with the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in the company's securities. This allows investors to monitor insider activity, which can provide insights into management's perspective on the company's value and prospects.

Comparison to Industry Standards

• Equity compensation in the form of restricted stock units (RSUs) is a common practice among publicly traded companies to align the interests of executives and directors with those of shareholders.
• The vesting schedule of the RSUs, which is quarterly over one year, is a typical vesting arrangement.
• The size of the RSU grant is relative to the size of the company and the director's role.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.
• The vesting schedule of the RSUs incentivizes the director to remain engaged with the company, which benefits stakeholders.

Key Dates